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Abstract
Introduction: Epileptic seizures and antiepileptic drugs (AEDs) are a source of oxygen 
stress. Oxygen stress can have negative effects. These effects which can be prevented are 
largely unknown in clinical epileptology. Objective: The objective of the study is to dis-
cuss (a) homeostatic oxidant, antioxidant imbalance due to epileptic seizures and AEDs, 
(b) the protective factors that help prevent oxygen stress (OS), and personalized medicine 
based on pharmacogenomics and diet as therapeutic challenges in epilepsy. Discussion: 
Experimental models of epileptic seizures evoked by various means suggest that seizures 
can cause neuronal destruction. This is accompanied by an increased activity of free radi-
cals and a reduction of total antioxidant capacity (in red blood cells, blood serum, and 
cerebrospinal fluid). A number of antioxidants have been found to attenuate the negative 
effects of OS and act neuroprotectively if they are administered prior to seizure occur-
rence: vitamins (C, E), trace elements (Se, Zn), melatonin, erdosteine, or natural herbal 
extracts. New AEDs (GBP, LEV, LTG, and TGB) cause no, or very little, OS as opposed to 
other drugs (CBZ, PHT, PB, VPA, TPM, or OXC), which have pronounced albeit hetero-
geneous and dose-dependent effects. It is suggested that AEDs should be administered 
together with free radical sweepers (vitamins, trace elements, electrolytes, melatonin) 
and other anti-oxidizing substances. Conclusions: (1) Epileptic seizures and AEDs cause 
OS. The effects vary greatly depending, among other things, on the daily drug dose. (2) 
The findings of research using a variety of seizure models are more unequivocal than the 
findings of research on patients with epilepsy. This suggests that the relations among 
seizures, AEDs, OS etiology, and OS consequences are complex. (3) Since existing AEDs 
cause OS, it is necessary to develop a new approach to AED treatment. (4) It is important 
to know the patient’s specific characteristics, including previous history, lifestyle, age, 
gender, weight, diet, environment, etc. They can be valuable tools to improve the quality 
of life of a person suffering from epilepsy. This concept of managing the patient health is 
called targeted medicine or personalized medicine.
© 2020 The Author(s). Licensee IntechOpen. Distributed under the terms of the Creative Commons Attribution-
NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution
and reproduction for non-commercial purposes, provided the original is properly cited.
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medicine
1. Introduction
Within the last three decades, interest in oxygen stress and its role in the development of 
organ pathology has increased considerably, and the importance of this phenomenon has 
been increasingly recognized. Oxygen stress means that the production of free radicals and 
reactive forms of oxygen (RFO) has exceeded the antioxidant defense mechanism capacity 
[1, 2]. Bartosz [3] thinks that RFO research may be the key to a better understanding of cer-
tain biochemical, physiological, and pathological aspects of living organisms and suggests 
that such understanding could be applied to clinical practice. Free radicals, the product of 
oxygen stress, may play an important role as physiological markers that control cell pro-
cess signals. However, when produced in excess, or when the antioxidant defense system is 
weak, they may lead to cell injury.
Excessive free radical production is related to various physiological and pathological states 
such as aging, epileptic seizures, or the use of xenobiotics, including fat-soluble drugs [4, 5]; 
this also applies to antiepileptic drugs (AEDs) [6–8]. A number of nonspecific factors [9] as 
well as dietary habits affect the state of antioxidants in the healthy elderly [10]. This suggests 
that oxidation and anti-oxidation processes are rather ubiquitous and hence nonspecific.
As far as epilepsy is concerned, when the number of free radicals in the neuron increases, 
this interferes with the respiratory chain in the mitochondria, destabilizes the lysosomal 
membranes, and lowers the convulsion threshold [11–13]. Peroxydation of the neuronal mem-
branes modifies their electrophysiological properties and leads to an abnormal bioelectric 
discharge in the neurons.
Epilepsy is frequent in diseases involving dysfunction in the mitochondrial structures. It is 
a sign of energetic anomalies in the ATP synthesis due to ADP phosphorylation [14]. The 
mitochondria have vital functions such as energy production, cellular harm control, neu-
rotransmitter synthesis, and free radical production. It is not clear yet which of these functions 
are affected in epileptic seizures [15]. Liang and Patel found an increase in spontaneous and 
evoked epileptic attacks in a subgroup of mice with a partial inherent mitochondrial SOD 
deficit. This effect correlated with chronic mitochondrial oxygen stress (aconitase enzyme 
deactivation) and reduced oxygen use. They think that oxygen stress caused by free radi-
cal peroxides increases seizure susceptibility in this subgroup of mice. This susceptibility 
increases with age and also with increased environmental stimulation and the use of stimu-
lants. Oxygen stress and mitochondrial dysfunction may both cause and be caused by epi-
leptic attacks [16]. According to Dubenko and Litovchenko [17], the application of energy 
metabolism activators improves the clinical and electroencephalographic course of epilepsy. 
This has been demonstrated experimentally by positive histological changes. According to 
these writers, this treatment prevents neuronal harm and the development of encephalopathy.
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Research on various seizure models, in animals and humans, has shown that not only epilep-
tic seizures but also EEG discharges themselves may cause complex metabolic neural lesions 
and oxidation-antioxidant disequilibrium [18–21].
On the other hand, a number of experimental studies have shown that AEDs can also produce 
free radicals and significantly increase the peroxydation of neuronal membrane lipids and 
reduce the protective effects of antioxidants. These changes may lead to increased seizure and 
idiosyncratic drug effect frequency [7, 22–25]. PHT initiates an oxidation damage to proteins 
and fats in the maternal and embryonic liver tissue organelle in murine rodents [1].
A group of researchers have also found that oxidation stress and resistance to AEDs trigger 
adaptive mechanisms, i.e., production of endogenous antioxidant sweepers, which prevent 
the harmful effects of oxidation [26]. These researchers studied nitrogen oxide and endog-
enous antioxidant GSH sweepers, GSH-Px, complete (T) and superoxide dismutase (T-SOD), 
Mn-SOD, and catalase in the cerebrospinal fluid of children with various neurological dis-
eases. All the antioxidant parameters were the highest in the children with bacterial meningi-
tis compared with the other groups. In the epilepsy group, nitrogen oxide, GSH, and GSH-Px 
were higher than in the aseptic meningitis and control group [26]. The authors think that 
oxygen stress may be related to seizure pathology and that its reduction may lead to a better 
prognosis for the course of epilepsy.
Akarsu et al. [27] came to similar conclusions. They studied the state of oxidation in 21 chil-
dren with febrile seizures and 21 children without febrile seizures. They assessed the level of 
arginase and catalase in the red blood cells, malondialdehyde—an indicator of lipid peroxida-
tion (MDA)—and nitrogen oxide in the plasma and cerebrospinal fluid. The control group 
consisted of 41 children divided into three subgroups: (1) with fever, (2) without convulsions, 
and (3) without fever and without convulsions. Both fever and convulsions had a significant 
effect on the oxidation mechanism. Febrile and afebrile convulsions differed in their genera-
tion of oxygen stress. According to the authors, higher levels of oxygen stress may be a factor 
that protects against neuronal lesion during convulsions in afebrile convulsions.
Not only can oxygen stress initiate epileptogenesis, it can also worsen the course of epilepsy. 
Consistently with these conclusions, using antioxidants in conventional epilepsy therapy and 
hence attenuating oxygen stress could have a positive effect on the course of epilepsy [28]. 
Many researchers share this opinion, but few of them are clinical epileptologists. Earlier, a 
review was published of research on the possible role of oxygen stress in the early stages of 
epileptogenesis, both in animal models and humans [29]. There has also been discussion of 
attempts to use exogenous antioxidants which, according to many writers, have antieplepto-
genic properties (which AEDs do not).
It has been reported that refractory epileptic patients may benefit from pharmacogenetic test-
ing for variations in the genes encoding drug-metabolizing enzymes and drug transporters 
of AEDs [30]. Since the treatment options are limited, the use of personal medication, which 
could have beneficial effects in epilepsy treatment, is indicated [31]. The aim of personalized 
medication is to maximize the likelihood of therapeutic efficacy and to minimize the risk of 
drug toxicity. Specific genes have been linked to adverse drug reactions in the form of a severe 
rash in Stevens-Johnson syndrome [32, 33].
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2. Preventing oxidation stress due to epileptic seizures
Experimental research with animal models and clinical observation have shown that epilep-
tic seizures lead to a number of harmful activities in the brain: disturbed blood circulation, 
increased cerebrospinal fluid pressure, brain edema, and hypoxia, all of which lead to a 
sudden reduction of energy carriers (ADP, ATP, phosphocreatine) and pH neuron reduc-
tion. During seizures, arachidic acid is released in the postsynaptic membranes. This has an 
activating effect on presynaptic neuronal endings and leads to increased glutamate release. 
Arachidic acid also increases the production of free oxygen radicals, leading to increased 
lipid peroxidation. These in turn may activate phospholipase C and then lead to the release of 
arachidic acid from cellular membranes, setting a vicious circle in motion [3].
2.1. The metrazol seizure model (PTZ)
Intraperitoneally induced seizures in rats by means of PTZ rupture the blood-brain barrier. 
This has been demonstrated with Evans dye, used to mark the permeability of this barrier 
[34]. Research suggests that free radicals are involved in the permeability of the blood-brain 
barrier; this permeability leads to albumin extravasation to the thalamic nuclei, brain stem, 
frontal cortex, and occipital cortex. The animals that have been given vitamin E or selenium 
(Se) prior to the seizure induction had less extravasation in these structures. It has also been 
demonstrated that in young rats in normothermic conditions, the barrier permeability was 
greater in males (p < 0.05) [35].
In this convulsion model in mice, prior administration of erdosteine (mucoliticum), which 
acts as an antioxidant, leads to much weaker oxygen stress and much longer latency time 
from pentylenetetrazol (PTZ) administration to convulsion onset (p < 0.05) [36]. On the other 
hand, compared with the control group, the experimental group had lower levels of MDA 
and xanthine oxidase (oxidizers) and a higher level of SOD (p < 0.001). These studies show 
that administration of erdosteine reduces convulsion-induced oxygen stress and therefore 
protects the neurons.
In mice, Nigella sativa oil (NSO), a powerful antioxidant that has been in used in folk medicine 
and the kitchen for thousands of years, prevented epileptic seizures induced by PTZ kindling 
much more effectively than valproic acid (VPA) [20].
2.2. The kainic acid model
Kainic acid (KA) is used as a model substance in the assessment of neurotoxicity. It leads to 
excessive RFT production due to reduced antioxidant activity. When KA was administered 
to rats, lipid peroxidation of the neuronal membrane increased in proportion to seizure pro-
gression [37]. In the same model, SOD and catalase activity increased significantly on day 5 
following KA administration and returned to the base level 3 weeks later; GGH-PX activity 
also increased significantly on day 5 but was still high 3 weeks later [38]. Lipid and protein 
peroxidation, assessed by MDA concentration, increased significantly 8 and 16 h later then 
decreased on day 2 and day 5 following KA injection. The authors attribute the rapid increase 
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in MDA and protein peroxidation to free radicals produced in this phase of the pathological 
KA effect; they think that the changes in the enzymatic scavenger activity and the reduced 
MDA concentration may have been caused by glia proliferation due to neuronal death.
In the KA model in mice, prior or simultaneous administration of melatonin (a powerful 
hydroxyl radical scavenger) (20 mg/kg i.p.) had an anti-oxidizing effect and prevented lipid 
peroxidation, cerebral mitochondria DNA injury, and seizures [39].
In the KA model, prior administration of vineatrol significantly reduced the MDA level in 
rats’ brains but had no effect on the glutation level [40]. Doses exceeding 20 and 40 mg/kg 
lengthened the latency time to that of the first seizures. Additional administration of vineatrol 
30 and 60 min after KA administration significantly reduced seizure incidence. The authors 
suggest that vineatrol could potentially be administered in the epileptic state.
Sok et al. [21] studied the anticonvulsive effects of Petasites japonicum (BMP), a plant grown 
in East Asia and used for both culinary purposes and in folk medicine. Its root extracts are 
still used for headaches and asthma. Prolonged administration of BMP, prior to KA admin-
istration, reduced mortality in mice by one half, and administration of the BMP-I subfraction 
reduced convulsive seizures and also significantly reduced neuronal loss in parts CA1 and 
CA3 of the hippocampus. The authors suggest that BMP-I is the factor responsible for preven-tion of oxidization lesion in the mouse brain.
Hsieh et al. [41] tested a traditional Chinese herb (Gastrodia elata B1—GE) administered to 
treat epilepsy in a controlled study using the KA seizure model in rats. They found that prior 
administration of GE significantly reduced in vitro lipid peroxydation in the rats’ brains, an 
effect analogous to the effect of phenytoin (PHT—20 mg/kg). The authors think that GE has 
an antiepileptic effect and is a free radical scavenger. This antiepileptic effect may be at least 
partly attributable to the GE’s vanilla component [42].
2.3. The pilocarpine model
Pilocarpine, an imidazole alkaloid extracted from the leaves of the Pilocarpus jaborandi shrub, 
is a parasympathomimetic, cholinergic antagonist that acts similarly to acetylcholine. It is 
often used to evoke epileptic convulsions and epileptic states in animal models. The mecha-
nisms leading to seizures or status epilepticus are unknown. It is thought that oxygen stress 
plays an important role, but we still do not know which brain structures are more sensitive. 
Studies of the activity of catalase, a free radical scavenger, have found different effects of the 
epileptic state on the catalase level in different brain structures [19]. The highest elevation was 
found in the hippocampus (36%), striatum (31%), and frontal cortex (15%); no changes in the 
level of catalase activity were found in the cerebellum. The authors think that the endogenous 
increase in the catalase activity, responsible for removal of free oxygen radicals produced 
during convulsions, may be a compensatory defense mechanism that counteracts the nega-
tive effects of oxygen stress in the status epilepticus. Other researchers have come to similar 
conclusions [26, 43]. Tejada et al. [43] evoked a pilocarpine epileptic state and found that 
MDA increased significantly (64%), suggesting oxygen injury. They found a simultaneous 
increase in the anti-oxidizing activity of catalase enzymes (28%), GSH-Px (28%) and SOD 
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(21%). On the other hand, vitamin E concentration in the cerebral cortex was reduced (15%) 
due to increased lipid peroxydation following pilocarpine administration.
Barros et al. [18] applied the same model and found that administration of vitamin E (200 
mg/g i.p.) 30 min prior to the administration of pilocarpine (400 mg/kg s.c.) led to increased 
(214%) catalase activity in the hippocampus compared with rats given only pilocarpine (67%) 
or physiological saline. The authors think that increased catalase activity may be responsible 
for the regulation of free radicals evoked by the status epilepticus.
In this same model in rats, prior administration of vitamin C (250 mg/kg i.p.) reduced the 
negative effects of oxygen stress and neuronal lesion [44]. The latency time to convulsion 
onset following pilocarpine administration was longer, and mortality in the status epilepticus 
was reduced compared with the group which did not receive vitamin C or received physi-
ological saline. This study also demonstrated that in the group receiving only vitamin C, the 
level of lipid peroxidation was lower than in the group that received (a) pilocarpine and (b) 
pilocarpine and vitamin C. In all the experimental groups, catalase activity in the hippocam-
pus increased compared with the control group which only received physiological saline. 
The authors think that the neuroprotective function of vitamin C in adult rats may be due to 
reduced lipid peroxidation and increased catalase activity following convulsions and status 
epilepticus [44].
2.4. The audiogenic seizure model
Prolonged melatonin administration to rats congenitally predisposed to audiogenic convul-
sions (the Krushinsky-Molodkina model) had no effect on seizures evoked by a 20 times more 
powerful auditory stimulus [45]. VPA administration significantly reduced convulsions, but 
VPA and melatonin combination had a significantly larger anti-seizure effect—it lengthened 
the latency time and reduced seizure severity. However, the rats receiving the combined 
treatment displayed a much more rapid onset of myclonia than the rats receiving either VPA 
or melatonin [45].
3. Counteracting AED-evoked oxygen stress
3.1. AEDs in animal models of epileptic seizures
Researchers using animal models have found a variety of effects of AEDs, administered in 
various doses, on oxidant and antioxidant processes in an astrocyte culture in rats [46]. Here 
is a selected list of studied variables: LDH and GS levels, RFT production, lipid peroxidation, 
and DNA fragmentation. Drugs such as CBZ, TPM, and OXC caused oxygen stress what-
ever their dose. GBP, LEV, LTG, and TGB, on the other hand, caused no significant metabolic 
changes whether given in large or small doses. Cortical astrocytes seem to tolerate this latter 
group of AEDs better than the former group.
In a similar model of rat cortical cell culture, VPA was found to protect against the negative 
effects of oxygen stress [47]. Administration of VPA for 7 days prevented lipid and protein 
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oxidization anomalies. The authors think that by preventing the accumulation of free radicals, 
VPA affects one or more of the neuroprotective processes.
VPA is a relatively safe drug, but it can sometimes be related to allergic idiosyncratic hepa-
topathy, a rare condition but more frequent in children less than 2 years of age taking more 
than one type of AED. The mechanism of toxic hepatopathy is unknown, but it has been 
suggested that it is caused by oxygen stress which leads to excessive RFT production and 
reduction of total antioxidant capacity [48, 49]. Therefore, therapeutic strategies or specific 
medicines that reduce oxygen stress may protect against toxic hepatopathy in patients taking 
VPA. Sabayan et al. [49] have hypothesized that garlic (allium) preparations may prevent this 
liver damage by removing free radicals and preventing the reduction of glutathione activity 
which accompanies the treatment with VPA.
TPM with its many mechanisms of action has undoubted effectiveness in the treatment of 
epilepsy in children. However, TPM administered in rat stomachs for 3 months may lead to 
such adverse effects as toxic liver dysfunction [50]. In a study of young rats, it was found that 
small doses of TPM (40 mg/kg a day) might reduce total antioxidant capacity in the organism 
and lead to a minor liver pathology. Large doses of TPM (80 mg/kg a day) or a combination of 
TPM (40 mg/kg) and VPA (300 mg/kg a day) significantly increased the risk of such adverse 
effects. Glutathione levels in the liver were significantly lower in the rats given large doses of 
TPM and in the rats on the TPM + VPA regime than that in the rats taking small doses of TPM 
and the controls given only distilled water. Histopathological examination also revealed dis-
seminated punctual necrosis as well as lipid and degenerative changes in some hepatocytes.
In this same model, TPM (40 and 80 mg/kg i.p.) had no effect either on rats’ status epilepticus 
or mortality, but larger doses significantly reduced KA-evoked lipid peroxidation [51].
LEV (2000 mg/kg i.p.) administered prior to pilocarpine administration (400 mg/kg s.c.) in 
mice prevented peroxidation increase in the hippocampus (but did not increase the nitrate 
level or reduce catalase activity in the hippocampus or cortical glutation) [52]. Perhaps the 
anti-oxidizing, neuroprotective effect of LEV and the consequent reduction of oxygen stress 
can be attributed to a different mechanism than the one which is active in the case of other 
AEDs.
In the KA convulsion model in rats, pre-convulsion administration of zonisamide led to an 
increased antioxidant level in the hippocampus [53]. The authors think that zonisamide has 
neuroprotective properties against free radicals.
LTG does not lead to detectable increases in lipid peroxydation in rats in vivo [54]. The antiep-
ileptic effectiveness of LTG in the partial complex epilepsy model (stimulation of the dentate 
gyrus) in rats was in reverse proportion to the level of activity of nitrogen oxide [55].
3.2. AEDs in human epilepsy
When used in human epilepsy, AEDs have various but equivocal effects on the oxidization 
processes [7, 22]. The authors studied the effects of epilepsy and prolonged AED treatment 
(CBZ, PHT, and VPA) on the levels of trace elements, electrolytes, and oxidization and 
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anti-oxidization activity in the blood serum in 70 patients with epilepsy and 14 untreated 
patients with epilepsy (controls) [7, 22]. They found increased Zn, Ca, Na, MDA, and GSH-Px 
and reduced copper, ceruloplasmin, and total antioxidant capacity in the treated patients 
(especially in those treated with VPA); treatment had no effect on the levels of Se, Mg, and 
K. In the untreated patients with epilepsy, uric acid (a powerful free oxygen radical scaven-
ger) was elevated but the total antioxidant capacity in the serum was reduced, suggesting that 
different antioxidants had different activities in this epileptic group.
According to these authors, some nutrients may have a positive effect on the reduction of sei-
zure frequency (vitamin B
6
, vitamin E, Mg, Mn, taurine, glycine, omega-3 fatty acids; vitamin 
B1 may improve cognitive functioning in patients with epilepsy).
In order to prevent the negative effects of LPP, prophylactic or therapeutic replenishment 
of folic acid, vitamin B
6
, vitamin D, and l-carnitine may be advisable. Vitamin K is recom-
mended toward the end of pregnancy in women taking AEDs. In some cases melatonin may 
reduce seizure frequency. However, supplementation can very seldom substitute AEDs com-
pletely [56].
Mahle and Dasgupta [1] found that PHT monotherapy significantly increased lipid hydro-
peroxidase in blood serum concentration compared with the control group. The total blood 
serum antioxidant capacity was lower in patients than in healthy controls. These researchers 
found a weak correlation between lipid hydroperoxidase concentrations, trygliceridemia, and 
cholesterol level in the serum of patients with epilepsy.
The negative consequences of oxygen stress in the serum were significantly larger in women 
with epilepsy treated with PHT monotherapy than in healthy women and women with 
untreated epilepsy [57]. According to the authors, as an addition to glutathione to PHT treat-
ment, modification of the activity of CuZn-SOD enzymes and reduction of copper absorption 
during pregnancy may prevent the incidence of the aforementioned, albeit somewhat con-
troversial, fetal phenytoin syndrome [58]. PHT is very rarely administered to patients with 
epilepsy in Poland (1–2%) and probably only exceptionally to epileptic women in reproduc-
tive (childbearing) age.
Comparative studies of the effects of PHT and CBZ monotherapies found a significant 
increase in the blood serum level of MDA and CuZn-SOD and a significant reduction of glu-
tathione in patients treated with PHT compared with a healthy control group and a group 
with untreated epilepsy [59]. No differences were found for CBZ except for a slight increase 
in CuZn-SOD activity. All in all compared with PTH, CBZ caused fewer interferences with 
antioxidant activity, lipid peroxidation, and level of trace elements (Cu, Zn).
VPA used in monotherapy for 60 days in 50 children with epilepsy (mean age 8.5 ± 3.6 years) 
led to liver dysfunction, free radical production, and DNA oxidation injury in the liver cells 
and neurons. The general oxidation state, measured by the level of 8-hydroxy-2-deoxyguano-
sine (8-OHdG), depended on the drug dose [60]. A linear relation was found between the 
VPA serum level and the lipid peroxidation magnitude. In a group of children with a VPA 
concentration 114 ± 9.7 μg/ml, peroxidation was significantly higher than in a control group 
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of children with a VPA concentration 81.0 ± 8 μg/ml. Free radicals caused DNA oxygen injury 
due to a significant increase in the serum level of 8-OHdG, which may be a good biological 
indicator of increased risk of VPA-evoked degeneration.
Other researchers have also found a linear relation between lipid peroxidation and the VPA 
level in the plasmas of patients with epilepsy [4]. They measured lipid peroxidation spec-
trofluorometrically, before and after Fenton reaction evocation, in 75 patients and 4 healthy 
controls. Interestingly, lipid peroxidation was higher in patients with partial epilepsy than 
in patients with generalized epilepsy and higher in women than men. Gender differences in 
oxygen stress effects have also been found in PHT-treated patients with epilepsy [57], PTZ rat 
models [35], and hippocampal sections in patients [61].
A comparative study of the effect of 2-year VPA and CBZ monotherapies on changes in the 
antioxidant system in children with epilepsy found significant differences in the effects of 
both AEDs [62]. The researchers measured the level of glutation, GSH-Px, red blood cell SOD, 
and serum lipid peroxidation. They studied two groups: (1) 25 healthy children and (2) 27 
children with epilepsy untreated prior to the study onset, 14 of whom were treated with VPA 
and 13 with CBZ. The treatment lasted 2 years. Laboratory tests were conducted in treatment 
months 13 and 24. The antioxidant systems in the children taking VPA for 2 years were more 
altered than the antioxidant systems of the children taking CBZ.
Another comparative study of the effects of CBZ and VPA on epileptic children found no dif-
ferences in the serum concentrations of Cu, Zn, Mn, Se, and Mg [24]. The only difference was 
found for the GSH-Px activity which was significantly higher in the VPA group. There were 
no differences in the SOD levels.
A more recent comparative study of the effect of VPA, CBZ, and PB monotherapies on the oxi-
dation and anti-oxidation systems in children with epilepsy yielded slightly different results 
[6]. The control groups consisted of children with untreated epilepsy and healthy children. 
The researchers found that the level of total antioxidant capacity in the serum was signifi-
cantly reduced in the group with untreated epilepsy compared with the healthy group. The 
level of peroxidation was significantly elevated in both the untreated group with epilepsy 
and the CBZ treatment group compared with the healthy controls. The pattern of results was 
similar for the children treated with PB and for the control group. According to the authors, 
children with epilepsy are at risk of oxygen stress due to seizures and AEDs. Their oxidation 
and anti-oxidation processes are unbalanced. VPA restores this balance more effectively than 
CBZ or PB.
Bolayir et al. [63] studied the effect of OXC on anti-oxidation processes in 13 adult patients 
with epilepsy prior to monotherapy and after 1 year of monotherapy. They also studied 15 
healthy controls. They measured lipid peroxidation activity, SOD, GSH-Px, and catalase in 
the red blood cells. The patients had significant differences in the levels of GSH-Px and SOD 
after 1 year of treatment compared with the pre-treatment levels. The MDA level was also 
significantly different from the level of the control group and from that assessed before the 
treatment. These findings suggest that the anti-oxidation systems in patients treated with 
OXC are negatively affected after 1 year of treatment.
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3.3. Dietary management in epilepsy
The idea that a specific way of eating can affect epilepsy was (recognized) first postulated by 
Hippocrates, who noticed that fasting could prevent convulsions [64]. All forms of dietary 
therapy that can be used for epilepsy involve ketogenic [65–68] medium-chain triglyceride, 
modified Atkins, and low-glycemic index diets that restrict carbohydrates and increase fat in 
the diet. However, most of these metabolic treatments for epilepsy can cause some side effects 
and nutritional deficiencies such as diarrhea, constipation, nausea, vomiting, and increased 
acid reflux. There is growing interest in ketogenic diet and it is available in many countries. 
The reasons why ketogenic diet prevents seizure are not fully understood. One hypothesis 
is that the ketones produced by the diet are able to enter the brain and reduce the levels of 
reactive oxygen species and make the brain use energy more efficiently, resulting in fewer 
seizures [69, 70]. It has been shown that ketogenic diet can produce a significant reduction in 
seizure frequency in the elderly as well [66, 71, 72].
3.4. Vitamins and minerals
Long-term use of antiepileptic drugs can affect the vitamin and mineral status in epilepsy 
patients. Antiepileptic drugs have been shown to decrease the levels of the B group vitamins 
such as folate and vitamins B
6
 and B12 [73, 74], which are important for controlling the metabo-lism. For example, the low folate levels caused by AEDs lead to high levels of homocysteine, 
a risk factor for heart disease [74–76]. Epileptic patients have reduced folic acid levels due 
to the use of AEDs [77]. It has been reported that epileptic patient using AEDs should be 
supplemented with B vitamins, especially with the metabolically active form of folic acid, 
l-methylfolate, to reduce the homocysteine levels [78].
Significantly lower levels of vitamin D are found in the blood of patients taking antiepileptic 
drugs. The explanation is that the use of AEDs increases the liver enzyme activity of cyto-
chrome P450, which is involved in breaking down of vitamin D [79–83]. Therefore, patients 
who are taking AEDs may need to take vitamin D and calcium supplements [84].
Pyridoxine-dependent epilepsy is a rare autosomal recessive disorder characterized by a 
combination of various seizure types that usually occurs during the first hours of life and 
is unresponsive to standard anticonvulsants, responding only to immediate administration 
of pyridoxine hydrochloride (vitamin B
6
) [85–87]. However, not all types of seizures can be 
treated with pyridoxine, but a potentially effective option is the biologically active form of 
vitamin B
6
 (pyridoxal-5-phosphate) [88–90].
Other antioxidants that have been reported to have the capacity to mitigate mitochondrial 
oxidative stress in the brain and lower seizure frequency in epilepsy include vitamin E, vita-
min C, and selenium [91–97]. Vitamin E is shown to prevent several types of seizures in ani-
mal models [98, 99]. Epileptics are also more likely to have low vitamin E levels, though this 
may be a result of taking antiepileptic drugs [100].
Magnesium is essential for enzyme function including ATP-generating reactions [101]. It 
stimulates the production of prostacyclin and nitric oxide [102], supports mitochondrial 
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integrity, and modulates ion transport [103, 104]. Magnesium has been shown to be associated 
with many health conditions; for example, it is essential for brain function and development 
[105, 106]. Epileptics have significantly lowered serum magnesium levels, and the seizure 
activity correlates with the level of hypomagnesemia [107–109].
3.5. Melatonin
Numerous studies on melatonin conducted over the last 30 years have confirmed that this 
neurohormone is susceptible to circadian rhythms, has antioxidant properties, and modulates 
immunological activity [110]. Melatonin affects the blood platelets and prolongs their life. It is 
transported by platelets to all body tissues. Thanks to its lipophilic function, it crosses the cell 
membranes easily, regulates blood-tissue exchange, and interacts with the endothelial cells. 
Platelets can behave like mobile and wandering serotonergic and/or melatonergic elements, 
comparable with cerebral neurotransmitter release [111].
Melatonin was found to be a potent free radical scavenger, and therefore it reduces oxygen 
stress and prevents excessive arousal from injured neurons as demonstrated with various 
animal models and humans.
The neuroprotective effect of melatonin was confirmed in a randomized, double-blind trial 
with epileptic children receiving VPA monotherapy [112]. The researchers administered VPA 
+ melatonin to 15 children and VPA + placebo to 14 children for 14 days. The posttest GSS-R 
level was significantly higher (p = 0.05) in the VPA + melatonin group, and the percentile dif-
ference in the value of this enzyme was also significant (p = 0.005).
Gupta et al. [113] found that CBZ and VPA administered in monotherapy to 22 children with 
epilepsy had differential effects on the blood serum levels of melatonin. In both groups the 
researchers measured endogenous and exogenous melatonin 30 min after administration. The 
serum level of melatonin was higher in the CBZ group (165 pg/ml ± 50–350) than in the VPA 
group (78 pg/ml ± 13–260). The authors think that these differences in the level of melato-
nin can be attributed to different effects of these two AEDs, additional epilepsy and CBZ-
dependent RFT increase, or differences in melatonin kinetics in conditions of oxygen stress. In 
a study by the present author [29], adding melatonin to the patients’ regular AED for several 
weeks did not affect seizure frequency in cases in which the course of the epilepsy was severe.
3.6. Selenium
The neuroprotective effect of selenium, one of the trace elements, is related to selenoproteins 
which are antioxidants [114]. Selenium insufficiency has been found in young children with 
severe mental retardation and drug-resistant epilepsy [115]. Oral administration of selenium 
(3–5 μg/kg m.c.) reduced seizure frequency, improved EEG recordings, and normalized liver 
activity. In another study, the serum level of selenium in 30 patients with intractable epilepsy 
was also lower (66.88 ng/ml ± 17.58) than in healthy controls matched for age, socioeconomic 
status, and place of residence (85.93 ng/ml ± 13.93) (p < 0.05) [116]. However, the low selenium 
level in the blood serum did not correlate with the measured risk factors for drug-resistant 
epilepsy: age of onset, infant seizures, neurological disorder, or etiology of epilepsy.
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The clinical implications of these results, and those quoted above, should be interpreted care-
fully because epilepsy is such a complex and heterogeneous disease, as suggested by the 
findings reviewed in this article.
3.7. Drug-resistant epilepsy: polytherapy
Drug-resistant seizures force the physician to use polytherapy with various AEDs. Polytherapy 
increases the production of free radicals and disturbs mineral balance to a greater extent than 
monotherapy, leading to increased oxygen stress. Both increased free radical production and 
inhibition of the enzymes that remove scavengers lead to adverse states and aggravation of 
the morbid process [22, 117].
Patients with epilepsy and on long-term AED therapy are at greater risk of atherosclerotic 
changes in the arteries [118]. Metabolic dysfunctions in these patients have been attributed 
to altered homocysteine, lipid and lipoprotein metabolism, and uric acid. According to the 
authors, these dysfunctions are indications for routine antioxidant multivitamin supplemen-
tation (folic acid, B12, B6, C and E, and beta-carotene). The protective, anti-atheromatic effect of vitamins is based on their antioxidant and anti-inflammatory properties. However, in the 
other research quoted above, increased lipid hydroperoxidase concentration had only weak 
correlations with the risk factors for vascular changes (triglyceridemia, cholesterolemia) [1].
Tupeev et al. [119] found a positive effect of prolonged vitamin E treatment (600 mg/day) 
in patients with generalized seizures: seizure frequency was reduced, EEG improved, and 
antioxidant activity increased.
Assuming that AEDs can trigger free radical production and lipid peroxydation, Hung-Ming 
et al. [23] studied the effects of TW970, a modified version of the Chinese herbal specific 
chaihu-longu-muli-tang which has antiepileptic and antioxidant properties. They administered 
it for 4 months to 3 groups of patients: (1) 20 patients with drug-resistant epilepsy (at least 4 
attacks a month), (2) 20 patients with mild epilepsy (fewer than 4 attacks a month), and (3) 
a control group of 20 healthy adults matched for age. The patients were tested prior to the 
introduction of TW970 and 4 months after the introduction. In the resistant group, seizure 
frequency dropped from 13.4 ± 3.4 to 10.7 ± 2.5 a month, but the difference was not significant 
(p = 0.084). Prior to the TW970 introduction, the resistant epilepsy group had significantly 
higher lipid peroxidation and increased MDA and CuZn-SOD activity, including reduced 
glutathione, compared with the healthy control group. After 4 months of TW970 treatment, 
the levels of MDA and CuZn-SOD normalized in the resistant epilepsy group, whereas no 
significant changes in the parameters were found in the mild epilepsy group, either prior to 
or following TW970 therapy. The authors suggest that TW970 may reduce seizure frequency 
in resistant epilepsy and that antioxidants may be responsible for this effect.
Many Native American plants are valued by local medical practitioners for their positive 
effects on health and a number of diseases, including epilepsy: Celastrus paniculatus L. (CP), 
Picrorhiza kurroa (PK), and Withania somnifera L. (WS). It has been found that extracts of these 
plants are dose-dependent free radical scavengers and that they prevent DNA injury due to 
oxygen stress. PK extract had a more powerful effect than CP or WS. These favorable biological 
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properties have been attributed to anti-stress, immune-modulating, anti-inflammatory, and 
antiaging effects [120].
3.8. The effects of surgery on AED-resistant temporal lobe epilepsy
López et al. [121] studied the activity of antioxidant enzymes (SOD, catalase, and GSH-Px) 
and markers of oxygen stress-induced molecular neuronal injury (MDA and RFT) before 
and at various moments after epileptic focus resection in 9 patients and a control group 
of 32 healthy individuals. All the studied variables normalized postoperatively except the 
SOD activity. Several other interesting observations seem to be somewhat related to these 
findings. Turkdogan et al. [122] found that increased lipid peroxidation in the plasma may 
be causally related to the presence of abnormal structural changes of the brain, as assessed 
by magnetic resonance (MR) rather than to the treatment of epilepsy, focal or generalized 
epileptic discharges in the EEG, duration of epilepsy, or to seizure frequency (more or fewer 
than 1 seizure a month). The authors found an increase in serum lipid peroxidation in 52 
children with epilepsy, treated with one or more AEDs and with an abnormal brain MR, 
compared with 16 healthy children (the difference was significant, p < 0.05). No significant 
differences in antioxidant enzymes were found in either group. The children with well-con-
trolled seizures and the ones with drug-resistant seizures but normal MRs had higher SOD 
activity than the children in the control group (p < 0.05). GSH-Px (an antioxidant) activity 
was not significantly different among the children with epilepsy and the control group [123]. 
This interesting and heterogeneous picture of enzymatic activity in children with epilepsy 
and control children suggests that the relations between various laboratory tests and numer-
ous variables associated with the heterogeneity and treatment of epilepsy are very complex. 
Although the authors took seizure frequency into consideration, they did not specify when 
the blood tests were taken relative to the experienced or imminent seizure nor did they 
report EEG recording of epileptic activity prior to the blood test. This makes it very difficult 
to interpret the causal relations among the results of the various tests and their epileptic 
correlates.
4. Conclusions
Epilepsy is a brain disease that has been linked with abnormal brain oxidation processes. 
Despite a vast spectrum of anticonvulsant therapies toward halting abnormal electrical activ-
ity in the brain, it may be suggested that antioxidants can perhaps in the future play a role 
in controlling seizures. Therefore, further study is necessary, in order to display whether 
widely accessible antioxidants such as vitamin C or vitamin E in fact possess the ability to 
synergistically act with anticonvulsant medications and whether this combination can result 
in improved control of epilepsy.
1. Research on animal models and patients with epilepsy suggests that both epileptic sei-
zures and AEDs (especially polytherapy), as well as other factors evoking oxygen stress, 
have a negative effect on the oxidation-anti-oxidation balance.
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2. AEDs and drug dosage have a differential effect on oxygen stress. The research findings 
are equivocal or even contradictory, however, with respect to the different AEDs. New 
AEDs usually have a more favorable effect on the oxidation and anti-oxidation enzyme 
balance and trace element and electrolytic homeostasis.
3. Neuroprotectors (trace elements, vitamins, and other antioxidants) help to reduce seizure-
induced oxygen stress, and therefore it is suggested that they should be used to supple-
ment AED treatment.
4. The fact that AEDs can lead to oxidation-anti-oxidation imbalance suggests that we need 
to adopt a new approach to the treatment of epilepsy and AED synthesis. We need to take 
the negative effects of oxygen stress into consideration.
5. No drug is completely safe and effective, and considering the complex and heterogeneous 
nature of epilepsy, it is evident that the optimal treatment of each individual case requires 
a carefully performed diagnosis and the application of research-based therapy, which 
includes the use of personalized medicine as well as drugs. Genes are influenced by the envi-
ronment and therapy. The value of food as medicine was acknowledged several centuries 
ago. Therefore, monitoring genomic information, pharmacogenomics, and the food-drug 
interactions is important as it helps to personalize the treatment to meet the patient’s needs.
6. It is important to know the patient’s specific characteristics including previous history, life-
style, age, gender, weight, diet, environment, etc. They can be valuable tools to improve the 
quality of life of the epileptic. Targeted medicine/personalized medicine is the concept of 
managing the patients’ health. It is believed that Hippocrates (c. 460 BC–c. 370 BC) was the 
one who applied this idea to medicine. He is best remembered today for his famous Oath “It’s 
far more important to know what person the disease has than what disease the person has.”
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